serena williams ro glp 1 discusses GLP-1 use as a celebrity ambassador Why Serena Williams Went Public

10.1016/j.bbamem.2022.184027 38 HurE

H.NguyenT

Open 3 , e2020836 (2020)

Top Weight Loss Medications

By Care Model: Physician-led virtual clinics Nurse-practitioner networks Async prescribing platforms Hybrid virtual-in-person By Revenue Model: Cash-pay subscription Insurance-reimbursed Employer contract Payer partnership Pharmacy-bundled By Service Scope: Prescribing & titration Lab ordering & monitoring Compounded GLP-1 supply Behavioral support By Patient Segment: Obesity/BMI-qualified Type 2 diabetes Cardiometabolic By End User: Direct consumers Employers Health plans Retail pharmacy By Region: North America Latin America Europe East Asia South Asia and Pacific Middle East and Africa - Frequently Asked Questions - Which Care Model leads the market